Results 31 to 40 of about 163,317 (263)

Molecular basis for modulation of the p53 target selectivity by KLF4 [PDF]

open access: yes, 2012
The tumour suppressor p53 controls transcription of various genes involved in apoptosis, cell-cycle arrest, DNA repair and metabolism. However, its DNA-recognition specificity is not nearly sufficient to explain binding to specific locations in vivo ...
Daniel P. Teufel   +29 more
core   +2 more sources

Benderamide A, a Cyclic Depsipeptide from a Singapore Collection of Marine Cyanobacterium cf. Lyngbya sp.

open access: yesMarine Drugs, 2018
Benderamide A (1), a (S)-2,2-dimethyl-3-hydroxy-7-octynoic acid (S-Dhoya)-containing cyclic depsipeptide that belongs to the kulolide superfamily, was isolated from a Singapore collection of cf. Lyngbya sp.
Chi Ying Gary Ding   +4 more
doaj   +1 more source

A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53. [PDF]

open access: yesPLoS ONE, 2016
p53 function is frequently inhibited in cancer either through mutations or by increased degradation via MDM2 and/or E6AP E3-ubiquitin ligases. Most agents that restore p53 expression act by binding MDM2 or E6AP to prevent p53 degradation.
John Bechill   +4 more
doaj   +1 more source

p53 β-hydroxybutyrylation attenuates p53 activity [PDF]

open access: yesCell Death & Disease, 2019
Abstract p53 is an essential tumor suppressor, whose activity is finely tuned by the posttranslational modifications. Previous research has reported that β-hydroxybutyrate (BHB) induces β-hydroxybutyrylation (Kbhb), which is a novel histone posttranslational modification.
Kun Liu   +13 more
openaire   +2 more sources

Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing

open access: yesMolecular Therapy: Nucleic Acids, 2014
Development of DNA aptamer screens that are both simple and informative can increase the success rate of DNA aptamer selection and induce greater adoption.
Wei Mei Guo   +6 more
doaj   +1 more source

USP11 regulates p53 stability by deubiquitinating p53 [PDF]

open access: yesJournal of Zhejiang University SCIENCE B, 2014
The p53 tumor suppressor protein coordinates the cellular responses to a broad range of cellular stresses, leading to DNA repair, cell cycle arrest or apoptosis. The stability of p53 is essential for its tumor suppressor function, which is tightly controlled by ubiquitin-dependent degradation primarily through its negative regulator murine double ...
Jia-ying, Ke   +7 more
openaire   +2 more sources

Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding

open access: yesFrontiers in Immunology, 2018
Many therapeutic antibodies are humanized from animal sources. In the humanization process, complementarity determining region grafting is tedious and highly prone to failure.
Wei-Li Ling   +6 more
doaj   +1 more source

P53 mutations in human adrenocortical neoplasms [PDF]

open access: yes, 1994
The mechanisms of tumorigenesis of adrenocortical neoplasms have not been elucidated as yet. However, loss of heterozygosity at chromosomal locus 17p has been consistently observed in adrenocortical cancer.
Travis, W.   +6 more
core   +1 more source

The Enigma of p53 [PDF]

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 2016
This perspective will focus on the physiological impact of wild-type and mutant p53 activities. In particular, the tissue-specific nature of activation of p53 targets and their subsequent effects on cell behavior will be discussed. Because mutations in p53 are common in human cancers, the regulation and physiological consequences of mutant p53 proteins
openaire   +2 more sources

PINTing for p53 [PDF]

open access: yesGenome Biology, 2013
A new study identifies the long noncoding RNA Pintas a regulator of cellular proliferation and a target of the p53 pathway.
openaire   +2 more sources

Home - About - Disclaimer - Privacy